BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20683973)

  • 21. Risk factors of acute hepatic failure during antituberculosis treatment: two cases and literature review.
    Smink F; van Hoek B; Ringers J; van Altena R; Arend SM
    Neth J Med; 2006 Nov; 64(10):377-84. PubMed ID: 17122456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatotoxicity of antituberculosis drugs.
    Ormerod LP; Skinner C; Wales J
    Thorax; 1996 Feb; 51(2):111-3. PubMed ID: 8711637
    [No Abstract]   [Full Text] [Related]  

  • 23. Antituberculous therapy and acute liver failure.
    Caplin M; Thompson N; Hamilton M; McIntyre N; Burroughs A
    Lancet; 1995 May; 345(8958):1171. PubMed ID: 7786346
    [No Abstract]   [Full Text] [Related]  

  • 24. [Antitubercular agents and hepatic complications].
    Ayoub A
    Tunis Med; 1984 Nov; 62(7):495-500. PubMed ID: 6531800
    [No Abstract]   [Full Text] [Related]  

  • 25. Nimesulide-induced hepatotoxicity and fatal hepatic failure.
    Bissoli F
    Singapore Med J; 2008 May; 49(5):436-7; author reply 438. PubMed ID: 18465058
    [No Abstract]   [Full Text] [Related]  

  • 26. [Liver injury under tuberculostatic treatment].
    Fattinger K; Braunschweig S; Reichen J; Meier-Abt PJ; Krähenbühl S
    Praxis (Bern 1994); 1997 Apr; 86(15):626-9. PubMed ID: 9213916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nimesulide-induced hepatitis and acute liver failure.
    Weiss P
    Isr Med Assoc J; 1999 Nov; 1(3):221. PubMed ID: 10731347
    [No Abstract]   [Full Text] [Related]  

  • 28. [Drug-induced iatrogenic hepatic lesions].
    Gola A; Lukasik S; Slończewski B; Swiderska T; Teresiak T
    Pol Tyg Lek; 1972 Jan; 27(5):179-80. PubMed ID: 5010764
    [No Abstract]   [Full Text] [Related]  

  • 29. [The impact of antituberculosis drugs upon liver function in patients with positive HBVM].
    Chen GQ
    Zhonghua Jie He He Hu Xi Za Zhi; 1989 Apr; 12(2):89-90, 126. PubMed ID: 2791129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatotoxicity of antituberculous drugs.
    Rao NK; Wadia RS; Karve SR; Grant KB
    J Assoc Physicians India; 1982 May; 30(5):295-8. PubMed ID: 7169440
    [No Abstract]   [Full Text] [Related]  

  • 31. [Antitubercular drug-induced liver injuries].
    Guo Y; Cui D
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):308-9. PubMed ID: 11326960
    [No Abstract]   [Full Text] [Related]  

  • 32. [Liver changes during treatment with antitubercular agents].
    Velojic D; Jankovic Z; MArsenic B
    Plucne Bolesti Tuberk; 1975; 27(1-2):53-60. PubMed ID: 1161927
    [No Abstract]   [Full Text] [Related]  

  • 33. Antituberculous therapy and acute liver failure.
    Durand F; Pessayre D; Fournier M; Belghiti J; Erlinger S; Bernuau J
    Lancet; 1995 May; 345(8958):1170. PubMed ID: 7723555
    [No Abstract]   [Full Text] [Related]  

  • 34. Acute liver failure following atorvastatin dose escalation: is there a threshold dose for idiosyncratic hepatotoxicity?
    Carrascosa MF; Salcines-Caviedes JR; Lucena MI; Andrade RJ
    J Hepatol; 2015 Mar; 62(3):751-2. PubMed ID: 25463547
    [No Abstract]   [Full Text] [Related]  

  • 35. [Fulminant liver failure caused by antitubercular drugs. Report of a clinical case].
    Girotto L; Gjonovich A; Preciso G
    Minerva Anestesiol; 2000 Apr; 66(4):249-51. PubMed ID: 10832275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antituberculosis drug-induced hepatitis and HBsAg carriers.
    Amarapurkar DN; Prabhudesai PP; Kalro RH; Desai HG
    Tuber Lung Dis; 1993 Jun; 74(3):215-6. PubMed ID: 8369519
    [No Abstract]   [Full Text] [Related]  

  • 37. Regarding "Management of antitubercular drug-induced hepatotoxicity and therapy reintroduction strategy in a TB clinic of Nepal".
    Anupa KC; Bista D
    Kathmandu Univ Med J (KUMJ); 2005; 3(3):310. PubMed ID: 18661667
    [No Abstract]   [Full Text] [Related]  

  • 38. A case of hyperacute hepatotoxicity in response to tuberculosis therapy.
    Hercus CG; Khoo JK; Jones TE
    Int J Tuberc Lung Dis; 2012 Dec; 16(12):1709-10. PubMed ID: 23131275
    [No Abstract]   [Full Text] [Related]  

  • 39. Acute liver failure caused by isoniazid in a child receiving carbamazepine.
    Berkowitz FE; Henderson SL; Fajman N; Schoen B; Naughton M
    Int J Tuberc Lung Dis; 1998 Jul; 2(7):603-6. PubMed ID: 9661830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute hepatic failure in seven patients after prophylaxis and therapy with antituberculous agents. Successful treatment with orthotopic liver transplantation.
    Meyers BR; Halpern M; Sheiner P; Mendelson MH; Miller C; Schwartz M; Mor E
    Transplantation; 1994 Aug; 58(3):372-7. PubMed ID: 8053063
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.